OROXYLIN A, AS A POTENTIAL INHIBITOR OF RHEUMATOID ARTHRITIS: IN SILICO EXPERIMENT BASED ON NETWORK PHARMACOLOGY AND MOLECULAR DOCKING
Oroxylin A is a potential inhibitory compound that could be applied to treat rheumatoid arthritis (RA). Rheumatoid arthritis is a chronic, systemic autoimmune disease that can lead to joint damage, deformity, and disability if not effectively treated. Current research utilizes network pharmacol...
Saved in:
| Main Author: | Nguyen Thi Thuy Tram, Cao Hoang Minh Chau, Ngu Thi Tra Giang, Phan Thi Thuy* |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Trường Đại học Vinh
2025-03-01
|
| Series: | Tạp chí Khoa học |
| Subjects: | |
| Online Access: | https://vujs.vn//api/view.aspx?cid=0793f0df-a326-4dc4-9c03-6cbdc25fcea9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oroxylin A suppressed colorectal cancer metastasis by inhibiting the activation of the TGF-β/SMAD signal pathway
by: Ji-Ping Cao, et al.
Published: (2024-10-01) -
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway
by: Xue Fan, et al.
Published: (2025-04-01) -
Network Pharmacology Integrated Docking Studies on Molecular Targets of Achyranthes aspera in the Treatment of Rheumatoid Arthritis
by: Sivasankari Marimuthu, et al.
Published: (2025-01-01) -
Potential Molecular Mechanisms of Paederia Foetida L. In Gout Treatment Through Network Pharmacology And Molecular Docking
by: Tuan Hoang Quoc, et al.
Published: (2025-04-01) -
Dual therapeutic potential of Scoparia dulcis in combating hyperglycemia and inflammation in diabetes through network pharmacology and in silico analysis
by: Ngoc-Thac Pham, et al.
Published: (2025-07-01)